Lowering the prophylactic platelet transfusion threshold: a prospective analysis

Area of Science:

• Hematology
• Oncology
• Transfusion Medicine

Background:

• The standard prophylactic platelet transfusion threshold of 20 x 10(9)/L is debated.
• Limited prospective studies exist on lower trigger values for platelet transfusions.

Purpose of the Study:

• To evaluate the safety and efficacy of a lower prophylactic platelet transfusion threshold (10 x 10(9)/L) compared to the standard threshold (20 x 10(9)/L).

Main Methods:

• A prospective, observational study was conducted over one year in hospitalized adult hematology-oncology patients.
• The prophylactic platelet transfusion threshold was set at 20 x 10(9)/L for the first six months (baseline) and 10 x 10(9)/L for the second six months (study period).
• Patients were monitored daily for hemorrhage and platelet transfusion use.

Main Results:

• Mean platelet transfusion use per patient per day was significantly lower with the 10 x 10(9)/L threshold (4.47) compared to the 20 x 10(9)/L threshold (6.48).
• Both prophylactic and therapeutic platelet transfusions decreased in the study period.
• Hemorrhage rates (major and minor) were slightly reduced in the study period, indicating no increase in bleeding with the lower threshold.

Conclusions:

• A prophylactic platelet transfusion threshold of 10 x 10(9)/L is safe and effective in hospitalized adult hematology-oncology patients.
• Lowering the platelet transfusion threshold can significantly reduce transfusion utilization.
• This strategy supports more conservative transfusion practices in oncology care.